Cisplatin neuropathy: clinical course and neurophysiological findings

Mauro LoMonaco; Margherita Milone; Anna Paola Batocchi; Luca Padua; Domenico Restuccia; Pietro Tonali

doi:10.1007/BF00839140

Cisplatin neuropathy: clinical course and neurophysiological findings

Mauro LoMonaco, Margherita Milone, Anna Paola Batocchi, Luca Padua, Domenico Restuccia, Pietro Tonali

Neurology

Research output: Contribution to journal › Article › peer-review

86 Scopus citations

Abstract

Sixteen patients treated with cisplatin (CDDP) 40 mg/m² on days 1-5 every 4 weeks for three courses (cumulative dose 600 mg/m²) were clinically and neurophysiologically tested before, during and 1, 3, 6, 9 and 12 months after CDDP administration. The first symptoms of polyneuropathy occurred in 4 of 9 patients after the second course (cumulative dose 400 mg/m²). One month after treatment 1 of 9 patients was asymptomatic, 5 complained of symptoms and 3 showed clinical and neurophysiological signs of polyneuropathy. Three months after CDDP all patients were affected. Clinical and neurophysiological signs of severity progression were noted up to 6 months after treatment with CDDP.

Original language	English (US)
Pages (from-to)	199-204
Number of pages	6
Journal	Journal of Neurology
Volume	239
Issue number	4
DOIs	https://doi.org/10.1007/BF00839140
State	Published - Apr 1992

Keywords

Cisplatin
Polyneuropathy
Sensory nerve conduction

ASJC Scopus subject areas

Neurology
Clinical Neurology

Access to Document

10.1007/BF00839140

Cite this

@article{1ba07e85fe7b4213857a70c059b54a56,

title = "Cisplatin neuropathy: clinical course and neurophysiological findings",

abstract = "Sixteen patients treated with cisplatin (CDDP) 40 mg/m2 on days 1-5 every 4 weeks for three courses (cumulative dose 600 mg/m2) were clinically and neurophysiologically tested before, during and 1, 3, 6, 9 and 12 months after CDDP administration. The first symptoms of polyneuropathy occurred in 4 of 9 patients after the second course (cumulative dose 400 mg/m2). One month after treatment 1 of 9 patients was asymptomatic, 5 complained of symptoms and 3 showed clinical and neurophysiological signs of polyneuropathy. Three months after CDDP all patients were affected. Clinical and neurophysiological signs of severity progression were noted up to 6 months after treatment with CDDP.",

keywords = "Cisplatin, Polyneuropathy, Sensory nerve conduction",

author = "Mauro LoMonaco and Margherita Milone and Batocchi, {Anna Paola} and Luca Padua and Domenico Restuccia and Pietro Tonali",

year = "1992",

month = apr,

doi = "10.1007/BF00839140",

language = "English (US)",

volume = "239",

pages = "199--204",

journal = "Journal of Neurology",

issn = "0340-5354",

publisher = "D. Steinkopff-Verlag",

number = "4",

}

TY - JOUR

T1 - Cisplatin neuropathy

T2 - clinical course and neurophysiological findings

AU - LoMonaco, Mauro

AU - Milone, Margherita

AU - Batocchi, Anna Paola

AU - Padua, Luca

AU - Restuccia, Domenico

AU - Tonali, Pietro

PY - 1992/4

Y1 - 1992/4

N2 - Sixteen patients treated with cisplatin (CDDP) 40 mg/m2 on days 1-5 every 4 weeks for three courses (cumulative dose 600 mg/m2) were clinically and neurophysiologically tested before, during and 1, 3, 6, 9 and 12 months after CDDP administration. The first symptoms of polyneuropathy occurred in 4 of 9 patients after the second course (cumulative dose 400 mg/m2). One month after treatment 1 of 9 patients was asymptomatic, 5 complained of symptoms and 3 showed clinical and neurophysiological signs of polyneuropathy. Three months after CDDP all patients were affected. Clinical and neurophysiological signs of severity progression were noted up to 6 months after treatment with CDDP.

AB - Sixteen patients treated with cisplatin (CDDP) 40 mg/m2 on days 1-5 every 4 weeks for three courses (cumulative dose 600 mg/m2) were clinically and neurophysiologically tested before, during and 1, 3, 6, 9 and 12 months after CDDP administration. The first symptoms of polyneuropathy occurred in 4 of 9 patients after the second course (cumulative dose 400 mg/m2). One month after treatment 1 of 9 patients was asymptomatic, 5 complained of symptoms and 3 showed clinical and neurophysiological signs of polyneuropathy. Three months after CDDP all patients were affected. Clinical and neurophysiological signs of severity progression were noted up to 6 months after treatment with CDDP.

KW - Cisplatin

KW - Polyneuropathy

KW - Sensory nerve conduction

UR - http://www.scopus.com/inward/record.url?scp=0026594021&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026594021&partnerID=8YFLogxK

U2 - 10.1007/BF00839140

DO - 10.1007/BF00839140

M3 - Article

C2 - 1317914

AN - SCOPUS:0026594021

SN - 0340-5354

VL - 239

SP - 199

EP - 204

JO - Journal of Neurology

JF - Journal of Neurology

IS - 4

ER -

Cisplatin neuropathy: clinical course and neurophysiological findings

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this